Bent Fransen
CEO, Expression Biotech
Replay available
ExpreS2ion Biotech Holding AB (publ) (EXPRS2) Q1 2025 Earnings Call
ExpreS2ion Biotech Holding AB (publ) (STO: EXPRS2) Q1 2025 earnings conference call, held 2025-05-15. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Expres2ion Biotech Holding Ab.
Replay transcript excerpt
WEBVTT 00:00:01.060 -- 00:00:04.710 to today's event where we have the pleasure to present Expression Biotech. 00:00:04.710 -- 00:00:07.980 So that was today's presentation. We are joined by CEO Ben Fransen. 00:00:07.980 -- 00:00:12.192 Today's topic, of course, the Q1 results, but I think maybe more the news flow that you 00:00:12.192 -- 00:00:17.296 have have sent out in this quarter and actually also rather large 00:00:17.296 -- 00:00:18.738 snoops 00:00:18.738 -- 00:00:23.324 after the quarter's end. So I think that will be the main focus of today's events. 00:00:23.324 -- 00:00:25.427 As always, you can ask questions in the box down below. 00:00:25.427 -- 00:00:29.853 We have already got a lot in advance, but do feel free to ask him. 00:00:29.853 -- 00:00:34.940 Do feel free to ask him in Danish, and I will try and translate to 00:00:34.940 -- 00:00:39.245 the best of my ability. But for now, I will hand the call over to you, Bent. 00:00:39.245 -- 00:00:41.586 Thank you, Michael. 00:00:41.588 -- 00:00:45.509 My name is Bent Fransen. I'm the CEO of Expression Biotech. 00:00:45.509 -- 00:00:50.958 i'm pleased to be reviewing the status of our company in business and pipeline 00:00:50.958 -- 00:00:55.966 today may 15 in connection with the release of our interim report 00:00:55.966 -- 00:00:58.167 for q1 00:01:01.796 -- 00:01:07.237 so the agenda for this meeting i'll first go through our strategic and financial 00:01:07.237 -- 00:01:11.583 review, you will notice that Keith Alexander, our CFO, is not present today. 00:01:11.583 -- 00:01:16.651 As usual, he is out on some travel commitments. 00:01:16.651 -- 00:01:22.120 Then I'll cover the ESOP C001 or therapeutic breast cancer program 00:01:22.120 -- 00:01:26.727 and where that is, and then the remaining pipeline ...